Diabetes Therapy View Homepage


Ontology type: schema:Periodical      Open Access: True


Journal Info

START YEAR

2010

PUBLISHER

Springer Healthcare

LANGUAGE

en

HOMEPAGE

https://link.springer.com/journal/13300

Recent publications latest 20 shown

  • 2022-05-18 Study Design and Baseline Characteristics of Patients with T2DM in the Post-marketing Safety Study of Dulaglutide in China (TRUST-CHN)
  • 2022-05-11 Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in Patients with Type 2 Diabetes Suboptimally Controlled by Basal Insulin in the UK
  • 2022-05-11 Bioequivalence Studies of New Generic Formulations of Vildagliptin and Fixed-Drug Combination of Vildagliptin and Metformin Versus Respective Originator Products in Healthy Volunteers
  • 2022-05-09 Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naïve People with Type 2 Diabetes: the ATOS Study
  • 2022-05-07 Oral Semaglutide: Dosage in Special Situations
  • 2022-04-27 Reductions in HbA1c with Flash Glucose Monitoring Are Sustained for up to 24 Months: A Meta-Analysis of 75 Real-World Observational Studies
  • 2022-04-26 Efficacy and Safety of LY2963016 Insulin Glargine in Chinese Patients with Type 1 Diabetes Previously Treated with Insulin Glargine (Lantus®): a Post Hoc Analysis of a Randomized, Open-Label, Phase 3 Trial
  • 2022-04-23 Correction to: Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria
  • 2022-04-22 Acute Administration of the GLP-1 Receptor Agonist Lixisenatide Diminishes Postprandial Insulin Secretion in Healthy Subjects But Not in Type 2 Diabetes, Associated with Slowing of Gastric Emptying
  • 2022-04-21 Profile of Patients with Diabetes Treated with Insulin Lispro 200 U/ml: A Real-World Study from Spain
  • 2022-04-20 Measuring the Impact of Flash Glucose Monitoring in a Pediatric Population in Saudi Arabia: A Retrospective Cohort Study
  • 2022-04-15 Observational Study on Unhealthy Eating Behavior and the Effect of Sodium-Glucose Cotransporter 2 Inhibitors: The Luseogliflozin Ehime Diabetes Study
  • 2022-04-14 Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Versus Originator Insulin Aspart Mix 70/30 (NovoMix 30) in People with Diabetes: A 26-Week, Randomized, Open-Label Trial (GEMELLI M)
  • 2022-04-13 Self-Monitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes Mellitus
  • 2022-04-13 Mortality in People with Type 2 Diabetes Following SARS-CoV-2 Infection: A Population Level Analysis of Potential Risk Factors
  • 2022-04-11 A Response to: Letter to the Editor with Regard to the Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: A Health Economic Analysis in Sweden
  • 2022-04-11 Cost-Effectiveness of Intermittently Scanned Continuous Glucose Monitoring Versus Advanced Hybrid Closed-Loop Systems in Type 1 Diabetes: Comment on Jendle et al.
  • 2022-04-08 The Emerging Role of Continuous Glucose Monitoring in the Management of Diabetic Peripheral Neuropathy: A Narrative Review
  • 2022-04-07 Testosterone Deficiency is Not Protective Against the Development of Adenocarcinoma of the Prostate in a Type 1 Diabetic Patient
  • 2022-04-05 Effects of Pentoxifylline on Serum Markers of Diabetic Nephropathy in Type 2 Diabetes
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "alternateName": "Research, treatment and education of diabetes and related disorders", 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "0.9350000023841858", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "0.9070000052452087", 
            "type": "Rating"
          }
        ], 
        "description": "

    Diabetes Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad, dedicated to the publication of high-quality clinical, observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions, including devices, across all areas of diabetes. The key features of the journal are:
    \n
    \nRapid publication: The journal aims for a 2-week peer review, 3-4 weeks from acceptance to online.
    \nOpen access: All articles published open access (CC-BY-NC)
    \nInclusivity: All scientifically sound research considered be it positive, confirmatory or negative data. Research is considered from pre-clinical, clinical phase, real-world and health economics outcomes studies. Submissions are welcomed whether they relate to an international or a country-specific audience.
    \nPersonal service: The journal’s team will re-format articles and upload submissions on behalf of authors, if necessary.
    \nDigital Features and Plain Language Summaries: These peer-reviewed features are welcomed to help enhance the educational value of a manuscript (for more information see “Author Information – Guidelines for digital features and plain language summaries” under “Submission guidelines”).
    \nPublication fees: Upon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of £4300/€5250/$6000. The journal will consider fee discounts and waivers for developing countries and this is decided on a case by case basis.

    \n", "editor": [ { "familyName": "Evans", "givenName": "Marc", "type": "Person" } ], "id": "sg:journal.1044057", "inLanguage": [ "en" ], "isAccessibleForFree": true, "issn": [ "1869-6953", "1869-6961" ], "license": "Fully Open Access", "name": "Diabetes Therapy", "productId": [ { "name": "dimensions_id", "type": "PropertyValue", "value": [ "44057" ] }, { "name": "nsd_ids_id", "type": "PropertyValue", "value": [ "488074" ] } ], "publisher": { "name": "Springer Healthcare", "type": "Organization" }, "publisherImprint": "Adis", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1044057" ], "sdDataset": "journals", "sdDatePublished": "2022-06-01T22:39", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/journal/journal_0.jsonl", "startYear": "2010", "type": "Periodical", "url": "https://link.springer.com/journal/13300" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1044057'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1044057'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1044057'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1044057'


     

    This table displays all metadata directly associated to this object as RDF triples.

    49 TRIPLES      21 PREDICATES      25 URIs      21 LITERALS      7 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1044057 schema:alternateName Research, treatment and education of diabetes and related disorders
    2 schema:contentRating N29ad6df061ba444b98ce2cf169dbfa25
    3 Nf6c906f5837f48679b9e3bbf804ab98c
    4 schema:description <p><em>Diabetes Therapy</em>&nbsp;is an international, open access, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad, dedicated to the publication of high-quality clinical, observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions, including devices, across all areas of diabetes. The key features of the journal are:<br /> <br /> <strong>Rapid publication</strong>: The journal aims for a 2-week peer review, 3-4 weeks from acceptance to online.<br /> <strong>Open access:&nbsp;</strong>All articles published open access (CC-BY-NC)<br /> <strong>Inclusivity:</strong>&nbsp;All scientifically sound research considered be it positive, confirmatory or negative data. Research is considered from pre-clinical, clinical phase, real-world and health economics outcomes studies. Submissions are welcomed whether they relate to an international or a country-specific audience.<br /> <strong>Personal service</strong>: The journal&rsquo;s team will re-format articles and upload submissions on behalf of authors, if necessary.<br /> <strong>Digital Features and Plain Language Summaries:&nbsp;</strong>These peer-reviewed features are welcomed to help enhance the educational value of a manuscript (for more information see &ldquo;Author Information &ndash; Guidelines for digital features and plain language summaries&rdquo; under &ldquo;Submission guidelines&rdquo;).<br /> <strong>Publication fees</strong>: Upon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of &pound;4300/&euro;5250/$6000. The journal will consider fee discounts and waivers for developing countries and this is decided on a case by case basis.</p>
    5 schema:editor N474c85e5927a42b0b337ef65c6139587
    6 schema:inLanguage en
    7 schema:isAccessibleForFree true
    8 schema:issn 1869-6953
    9 1869-6961
    10 schema:license Fully Open Access
    11 schema:name Diabetes Therapy
    12 schema:productId Nb4fafca99a2b45b98ea633494bb4ea18
    13 Ndcef0bf318b94540a818522af0c8c94f
    14 schema:publisher N2cf425c7a89c4479a64c73472df340a4
    15 schema:publisherImprint Adis
    16 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1044057
    17 schema:sdDatePublished 2022-06-01T22:39
    18 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    19 schema:sdPublisher Nd6854dc15e3545809d41a1eb84b6b39c
    20 schema:startYear 2010
    21 schema:url https://link.springer.com/journal/13300
    22 sgo:license sg:explorer/license/
    23 sgo:sdDataset journals
    24 rdf:type schema:Periodical
    25 N1205fe8a6ecf4be6b9839e273b66e780 rdf:first snip
    26 rdf:rest rdf:nil
    27 N29ad6df061ba444b98ce2cf169dbfa25 schema:author Nf82a9a23a7b24892b3a32824557f5aab
    28 schema:ratingValue 0.9070000052452087
    29 rdf:type schema:Rating
    30 N2cf425c7a89c4479a64c73472df340a4 schema:name Springer Healthcare
    31 rdf:type schema:Organization
    32 N474c85e5927a42b0b337ef65c6139587 rdf:first N835877ad442a423794096e4300d48858
    33 rdf:rest rdf:nil
    34 N835877ad442a423794096e4300d48858 schema:familyName Evans
    35 schema:givenName Marc
    36 rdf:type schema:Person
    37 Nb4fafca99a2b45b98ea633494bb4ea18 schema:name nsd_ids_id
    38 schema:value 488074
    39 rdf:type schema:PropertyValue
    40 Nd6854dc15e3545809d41a1eb84b6b39c schema:name Springer Nature - SN SciGraph project
    41 rdf:type schema:Organization
    42 Ndcef0bf318b94540a818522af0c8c94f schema:name dimensions_id
    43 schema:value 44057
    44 rdf:type schema:PropertyValue
    45 Nf6c906f5837f48679b9e3bbf804ab98c schema:author N1205fe8a6ecf4be6b9839e273b66e780
    46 schema:ratingValue 0.9350000023841858
    47 rdf:type schema:Rating
    48 Nf82a9a23a7b24892b3a32824557f5aab rdf:first sjr
    49 rdf:rest rdf:nil
     




    Preview window. Press ESC to close (or click here)


    ...